FDA Approves First Drug to Delay the Full Onset of Type 1 Diabetes
The FDA approval of teplizumab — brand name Tzield — was announced today on November 17, 2022 for use in people…
The Diabetes Link Launches to Help Young Adults Thrive While Living with the Disease
After 12 incredible years serving more than 11,500 students on over 300 campuses across 30 states, College Diabetes Network is…
Understanding Durable Medical Equipment: Why Reliability Matters
One of the most stressful parts of living with type 1 diabetes (T1D) is making sure you have the diabetes…
T1D Exchange Heads to ADA’s 82nd Scientific Sessions
The American Diabetes Association’s (ADA) 82nd Scientific Sessions are about to get started, and the T1D Exchange team is honored…
T1D in Film: Why Does Representation Matter?
If you’ve spent any time on social media recently, you’ve likely heard the buzz around the latest Pixar film, Turning…
Get Up Close and in the Know with Sean Salmon, President of Medtronic Diabetes
T1D Exchange recently had the opportunity to interview Sean Salmon, President of Medtronic Diabetes. In this interview, we discuss Medtronic’s…
Vertex Q&A: Promising New Data & Future of Cell Therapies
Vertex Pharmaceuticals, a global biotech company and forerunner in stem cell-derived therapies for people living with type 1 diabetes (T1D),…
An Interview with Dr. Enrique Caballero: Providing Culturally-Oriented Care to the Latinx Community
Meet Dr. A. Enrique Caballero: a Boston-based endocrinologist with decades of experience providing diabetes care to the Latinx community. After…
Connect1d Canada partners with the T1D Exchange
Connect1d Canada, a digital platform that allows those with type 1 diabetes (T1D) to easily learn about and participate in…
T1D Exchange Appoints Two New Members to its Board of Directors
T1D Exchange announced today the appointments of Dr. Margarita Ochoa-Maya and Dr. Kevin Larsen to its Board of Directors. Their…
